Potentially toxic effects of anaesthetics on the developing central nervous system.
A growing body of experimental evidence suggests that anaesthetics, by influencing GABAergic and glutaminergic neural signalling, can have adverse effects on the developing central nervous system. The biological foundation for this is that gamma-aminobutyric acid and glutamate could act non-synaptically, in addition to their role in neurotransmission in the adult brain, in the regulation of neuronal development in the central nervous system. These neurotransmitters and their receptors are expressed from very early stages of central nervous system development and appear to influence neural progenitor proliferation, cell migration and neuronal differentiation. During the synaptogenetic period, pharmacological blockade of N-methyl-d-aspartate (NMDA)-type glutamate receptors as well as stimulation of GABAA receptors has been reported to be associated with increased apoptosis in the developing brain. Importantly, recent data suggest that even low, non-apoptogenic concentrations of anaesthetics can perturb neuronal dendritic development and thus could potentially lead to impairment of developing neuronal networks. The extrapolation of these experimental observations to clinical practice is of course very difficult and requires extreme caution as differences in drug concentrations and exposure times as well as interspecies variations are all important confounding variables. While clinicians should clearly not withhold anaesthesia based on current animal studies, these observations should urge more laboratory and clinical research to further elucidate this issue.
Gascon
E
E
University of Geneva Medical School, Department of Anesthesiology, Pharmacology and Intensive Care, Geneva, Switzerland.
Klauser
P
P
Kiss
J Z
JZ
Vutskits
L
L
D000777:Anesthetics / Q000009:adverse effects*; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000254:growth & development; D002490:Central Nervous System / Q000187:drug effects* / Q000254:growth & development*; D018698:Glutamic Acid / Q000187:drug effects; D006801:Humans; D020258:Neurotoxicity Syndromes; D005680:gamma-Aminobutyric Acid / Q000187:drug effects
D000777:Anesthetics; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid